Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2026-01-04 @ 6:25 PM
Study NCT ID:
NCT04925193
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-24
First Post:
2021-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
Sponsor:
University of Colorado, Denver
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-18
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-19
First Submit QC Date:
None
Study First Post Date:
2021-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-20
Last Update Post Date:
2025-02-24
Last Update Post Date Type:
ACTUAL